Lv11
46 积分 2025-06-26 加入
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
28天前
已完结
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
28天前
已完结
Timeline and outcomes of viral and fungal infections after Chimeric Antigen Receptor (CAR) T-cell therapy: A large database analysis
2个月前
已完结
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
6个月前
已完结
皖公网安备34019202002308
